rubidium has been researched along with Mesothelioma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersson, B; Behnam-Motlagh, P; Engström, KG; Grankvist, K; Henriksson, R; Janson, V | 1 |
1 other study(ies) available for rubidium and Mesothelioma
Article | Year |
---|---|
Acquisition of cisplatin-resistance in malignant mesothelioma cells abrogates Na+,K+,2Cl(-)-cotransport activity and cisplatin-induced early membrane blebbing.
Topics: Bumetanide; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Cell Surface Extensions; Cisplatin; DNA Fragmentation; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; Humans; Mesothelioma; p38 Mitogen-Activated Protein Kinases; Rubidium; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2 | 2008 |